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Background: The aim of the present study was to determine whether different methods of
recording physical activity (PA), i.e., accelerometers vs questionnaires, provided similar infor-
mation in adults with cystic fibrosis (CF).
Methods: 20 CF (age 33 8SD yrs, FEV1 68 16% predicted) and 11 age-matched healthy controls
completed the Habitual Activity Estimation Scale (HAES) questionnaire and wore a biaxial accel-
erometer (SenseWear Pro3 Armband). Exercise tolerance was measured in CF.
Results: Patients had similar values in PA compared with controls. None of PA categories esti-
mated by HAES questionnaire correlated with PA categories measured by the accelerometer;
in CF the HAES questionnaire overestimated the effective levels of PA measured by the acceler-
ometer. There were no differences between weekdays and weekend days PA levels provided by
the accelerometer. In CF the questionnaire detected different time reported during the “some-
what inactive” and “somewhat active” categories (z Z 2.651; p Z 0.008; z Z 2.651;
pZ 0.008), weekdays vs weekend; patients reported more time spent in activity (somewhat
active& very active) during theweekend (zZ2.203; pZ 0.02). Peak oxygen uptake correlated
with accelerometer activities of “moderate” (>4.8 metabolic equivalents (METS)) and
“vigorous” (>7.2 METS) intensity (rZ 0.503, pZ 0.02; rZ 0.545, pZ 0.01).
Conclusions: In adults with cystic fibrosis PA levels are better evaluated by the accelerometer
and are similar to the controls. PA measured by the accelerometer is similar during the week
and correlates with exercise tolerance.
ª 2013 Elsevier Ltd. All rights reserved.49979291.
lio.it (D. Savi).
3 Elsevier Ltd. All rights reserved.
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Measuring habitual physical activity 1889Introduction accelerometer or questionnaire data related to the prog-In healthy individuals, exercise tolerance and the level of
daily physical activity are important determinants of health
status and mortality [1]. In patients with cystic fibrosis (CF)
exercise tolerance is usually reduced [2]. Importantly,
research studies have shown that peak oxygen uptake
(VO2 peak), maximal work rate (Workmax) and ventilatory
equivalents for oxygen uptake (VE/VO2) measured during
incremental cardiopulmonary exercise predict patients’
survival in CF [3]. Data obtained in young adults with CF
suggest that the level of daily physical activity (PA) may
have a positive impact on exercise tolerance, on nutritional
status [4] and on the rate of decline of FEV1 [5]. There is
also evidence that in CF patients improving physical activity
increases sputum clearance, improves respiratory muscle
strength and ultimately leads to better quality of life
[2,6,7]. Therefore exercise training programs have been
developed for CF to increase the patients’ ability to un-
dertake daily activities and to change their lifestyle to
maintain the positive effects of rehabilitation. Recently,
Troosters et al. showed in adults with CF that compared
with age-matched controls, mild intensity physical activity
was preserved while activity above moderate intensity was
significant reduced [8].
However, translating this growing interest in activity into
clinical practice has proven difficult, especially in adult CF
patients. Although recommendations on the use of exercise
testing in respiratory diseases are available [9], laboratory
exercise testing remains relatively underutilized in the
clinical setting of CF, probably because of its expense and
the lack of adequately trained staff [10]. Some workers
have used either VO2 peak during incremental exercise or a
6 min walking test as surrogate assessment of PA [4,11] but
how well these relate to objectively measured daily activity
in CF patients is unclear. To date there is relatively little
information about objectively measured PA in CF. Accel-
erometers can be used to accurately measure habitual PA
levels but they are more expensive than using one of the
questionnaires that have been developed. Although ques-
tionnaires have been utilized in chronic respiratory dis-
eases, such as COPD and CF, as an alternative to
accelerometers, their validity and reliability is debatable.
In small cohorts of CF patients, Wells et al. [12] and Ruf
et al. [13] found a significant correlation between levels of
PA, estimated by the Habitual Activity Estimation Scale
(HAES) questionnaire, and activity levels measured by the
use of accelerometers. However in these studies the pro-
portion of adult participants was relatively small. A recent
larger study in adult CF population using a validated ques-
tionnaire was conducted by Rasekaba et al., but the results
observed were not supported by objective measures of
activity levels [14].
Therefore, the primary aim of the present study was to
determine whether different methods of recording habitual
daily physical activity, i.e., accelerometers vs question-
naires, provide similar information in adults with CF. The
secondary aims were to detect possible differences in the
levels of PA during the week, i.e., weekdays vs weekend
days and to assess the relationships between pulmonary
function, exercise capacity, and physical activity.Specifically, we were interested to evaluate whether
nostically important variables derived from cardio-
pulmonary exercise testing.
Material and methods
Subjects
Twenty clinically stable adult CF patients (33  8SD years)
were recruited from the CF outpatient clinic at Policlinico
Umberto I Hospital (Sapienza University of Rome, Italy) and
11 age-matched healthy control subjects (30  4SD years)
were recruited from staff and colleagues of the same hos-
pital. Patients were excluded if they had unstable medical
conditions that could cause or contribute to breathlessness
(i.e., cardiovascular, metabolic, or other respiratory dis-
eases) or other disorders that could interfere with exercise
testing, such as neuromuscular diseases or musculoskeletal
problems. Patients with an exacerbation in the 4 weeks
prior to the study, patients on the waiting list for lung
transplantation and those who had undergone lung trans-
plantation were excluded from the study.
To be eligible for inclusion, the healthy control subjects
needed to be at least 18 years of age and free of cardio-
respiratory diseases; specifically, five of them were stu-
dents of the faculty of Medicine (Sapienza University of
Rome), four were physiotherapists and two were employed.
Study design
All subjects signed written informed consent at the time of
their first assessment and were familiarized with all pro-
cedures, questionnaire and symptom rating scale before
these were evaluated in the study. The ethical approval
was received from the Policlinico Umberto I Hospital
(Sapienza University of Rome, Italy). On the first visit, after
informed consent and appropriate screening of medical
history, all subjects underwent pulmonary function testing
but only the CF patients performed the 6 min walking test
(6MWT) and a symptom-limited incremental cardio-
pulmonary exercise test (CPET). Finally, patients and
healthy controls wore an accelerometer to assess daily
habitual PA and they were studied over four consecutive
typical days (including 2 weekdays and 2 weekend days). On
the second visit all subjects returned the accelerometer
and completed the HAES questionnaire.
Methods
Measurement of spirometry (COSMED PFT, Pavona Italy) was
performed according with recommended standards [15]. In
the patient group, spirometry was repeated 20 min post-
bronchodilator (albuterol 400 mg) and these data were
expressed as a percent of predicted [16].
CF patients performed the 6MWT in accordance with ATS
recommendations [17] with two additional practice walks
at the initial assessment. Perceived breathlessness was
scored immediately before and at peak exercise, using the
modified Borg scale [18]. A maximal incremental exercise
1890 D. Savi et al.test was conducted on an electronically-braked cycle
ergometer according to recommended guidelines [19].
CPET consisted of a 2-min rest period, then 2 min of
unloaded pedaling followed by a stepwise work rate in-
crements of 10e20 Watt/min, depending on patient’s
height. The test was continued until exhaustion and sub-
jects stated their main reason for stopping exercise, i.e.,
breathlessness, leg discomfort or both. Arterial oxygen
saturation (SpO2), heart rate (HR), and blood pressure (BP)
were measured during CPET. Tidal volume VT, breathing
frequency (f ) and O2 and CO2 expired gases were measured
breath-by-breath (COSMED Quark B2, Pavona, Italy) having
the subjects breathing through a turbine attached to a low
dead space face mask. A dedicated software calculated
minute ventilation (V0E), oxygen uptake (V0O2) and carbon
dioxide production (V0CO2).
Activity measurement
All patients and all healthy volunteers completed the HAES
questionnaire [20] for a typical weekday (either Tuesday or
Thursday) and Saturday within the past week. Percentage
of awake time was documented in each of four activity
categories: inactive, somewhat inactive, somewhat active,
and very active. Subjects referred to these descriptions
when completing their estimates: “inactive” (I) like lying
down, sleeping, resting; “somewhat inactive” (SI) like
sitting, reading, watching television; “somewhat active”
(SA) as walking, shopping, light household chores; “very
active” (VA) like running, jumping, skating, skipping. The
use of wakeup, bed, and meal times allowed the calcula-
tion of the total number of hours per day spent in each of
the four activity categories. Total activity (TA) was calcu-
lated as “somewhat active” þ “very active” and total
inactivity (TI) was calculated as “inactive” þ “somewhat
inactive” for each day. This questionnaire has already been
used in children with CF [21]. The test-retest reliability of
the HAES questionnaire was analyzed in CF by Wells et al.
who found a highly significant intra-class correlation coef-
ficient ICC Z 0, 72 [12].
Total body activity measurement
Habitual daily activity was assessed for four consecutive
typical days. We used the SenseWear Pro3 Armband
(BodyMedia Inc., Pittsburgh, PA, USA) positioned on the
upper right arm (on the triceps point), as recommended by
the manufacturer. The sensor contains a biaxial acceler-
ometer (longitudinal and transverse), a galvanic skin
response sensor, a heat flux sensor, a skin temperature
sensor and a near-body ambient temperature sensor from
which the data were stored minute by minute. Using spe-
cific software these variables, as well as body weight,
height, handedness and smoking status (smoker or non-
smoker) were used to estimate the intensity of PA,
expressed in metabolic equivalents (METS), total energy
expenditure, total physical activity duration, time lying
down and sleep duration. All subjects wore the armband
day and night only removing it for bathing or showering.
The outcome obtained from the armband was the time
spent in PA at different intensities and the definitions for
activity levels based on METS were those used by Troosters
et al. [8]. The time (in min) spent with an energy expen-
diture of >3 METS was considered “mild” activity (e.g.,walking at normal walking speed, carrying out light
household work), time spent at >4.8 METS was considered
“moderate” activity (e.g., brisk walking or cycling) and
activities with an energy expenditure of >7.2 METS were
considered “vigorous” (e.g., activity with training effects
when applied for a sufficient length of time and at an
appropriate training frequency) [22]. Finally, the number of
steps was measured.
Statistical analysis
Descriptive data are reported as mean, standard deviation
(SD), minimum and maximum values. Data from the accel-
erometer and HAES questionnaire were compared for the
same day (weekday or weekend). Data from the two
weekdays and the two weekend days activity levels
measured by the accelerometer were averaged to give a
single weekday and weekend value so as to match with the
weekday and weekend day reported by the HAES
questionnaire.
We used a KruskalleWallis test to compare the scores of
the questionnaire and the accelerometer between patients
and controls. The association between measures collected
during weekdays and weekend days both for the acceler-
ometer and the questionnaire was tested with the sign-rank
non parametric test (Z ) for matched data. The correlation
between the exercise physiological variables, and both the
items of the questionnaire and the measures collected by
the accelerometer, was evaluated by the Spearman corre-
lation coefficient, a non-parametric measure of statistical
dependence between two variables. The level of signifi-
cance was set at p <0.05. As these analyses were explor-
atory in nature no correction for multiple testing was
carried out.
Results
The baseline characteristics and pulmonary function data
for both groups are shown in Table 1. Most CF patients were
male, well nourished despite their pancreatic insufficiency,
chronically colonized by Pseudomonas aeruginosa and with
mild to moderate lung obstruction (80% > FEV1 > 40%
predicted). Control subjects were characterized by normal
values in all these outcomes.
The results of exercise testing (6MWT and CPET) per-
formed by CF patients are presented in Table 2. Aerobic
fitness, measured by V0O2 peak and expressed either as
absolute value or as function of body mass, as well the
maximal workload achieved, was reduced compared to our
laboratory normal values. By contrast, the 6 MW distance
was normal [17].
Habitual daily activities of the patients and of the age-
matched controls included in the study group are shown in
the Online supplement (Table E1). Compared with control
subjects, patients with CF had similar values in daily life
physical activities whether measured over four typical
consecutive days by the SW accelerometer or estimated by
the questionnaire.
As illustrated in Table 3, no significant differences be-
tween weekdays and weekend days activity levels,
measured objectively by the SW accelerometer were seen
Table 1 Characteristics of patients with cystic fibrosis
(CF) and controls.
Characteristics CF Control
Subjects n 20 11
Male:Female 15:5 7:4
Age, yr 33  8 30  4
BMI, Kg/m2 22  2 22  3
FEV1, L 2.6  0.6 4.2  0.7
FEV1, % predicted 68  16 108  11
FVC, L 3.9  0.8 5.2  0.9
FVC, %predicted 88  13 110  10
PI:PS 15:5
Pseudomonas aeruginosa
positive:negative
13:7
DF508 homozygous:heterozygous 6:12
Data are presented as mean  SD, unless otherwise stated. BMI:
body mass index; PI: pancreas insufficiency; PS: pancreas suf-
ficiency; FEV1: forced expiratory volume in 1 s; % pred: %
predicted; FVC: forced vital capacity.
Measuring habitual physical activity 1891in both groups, except for “vigorous intensity activities”
(z Z 2.396; p Z 0.016) performed by CF patients which
were more likely during the weekday period and for “lying
time” (z Z 2.215; p Z 0.02) which was higher during the
weekend in healthy subjects (more data available in Table
E2 of the online supplement). However the questionnaire
identified significantly different activity measures during
the course of the week in the CF patients, specifically at
the “somewhat inactive” and “somewhat active” cate-
gories (zZ 2.651; pZ 0.008; zZ 2.651; pZ 0.008). The
CF participants reported more time spent in activity
(somewhat active & very active) during the weekend
(z Z 2.203; p Z 0.02) and more inactivity time (some-
what inactive & inactive) on weekdays (z Z 2.464;
pZ 0.01). Finally, the age-matched control group reported
more “somewhat inactive” time during the weekend
(z Z 2.224; p Z 0.02).Table 2 Results of 6MWT and CPET in patients with cystic
fibrosis (CF).
Variable CF
6MWT, m 642  49
6MWT, % pred 106  8
W max, W 158  47
V0O2 peak, ml/min 1855  512
V0O2 peak, ml/min/kg 28.2  5.2
V0O2 peak % pred 69  11
HR max, beats min1 154  13
HR max, % pred 82  8
V0E max, l/min 70.0  19.2
V0E/V0CO2 32  4
Data are presented as mean  SD, unless otherwise stated.
6MWT: 6-min walking distance; W max: maximal work rate;
V0O2 peak: peak oxygen uptake; HR max: maximal heart rate;
V0E max: maximal minute ventilation.None of HAES questionnaire activity categories showed
significant correlations with PA categories determined by
accelerometer (data are given in the Online supplement
Table E3). The only significant correlation between phys-
ical activity, measured by accelerometer, and the in-
dividual’s activity level, estimated by the HAES
questionnaire, was found in patients with CF for the ques-
tionnaire category “total inactivity” vs accelerometer
category “lying time” (rZ 0.559; pZ 0.01) when assessed
during the weekend.
Peak exercise tolerance measured at CPET, i.e., V0O2
peak and Watt max, did not correlate with weekdays and
weekend activity categories detected by the HAES ques-
tionnaire. V0O2 peak, expressed relative to body weight,
correlated significantly with the average daily accelerom-
eter activities of “moderate” intensity (r Z 0.503,
p Z 0.02); particularly during the weekday recordings
(r Z 0.588, p Z 0.006). V0O2 peak, expressed as absolute,
also correlated significantly with the average daily accel-
erometer activities of “moderate” intensity (r Z 0.503,
p Z 0.02) and with physical activities above the threshold
of moderate (>4.8 METS) and vigorous (>7.2 METS)
(r Z 0.515, p Z 0.02) (Fig.1). V0O2 peak expressed as
percentage of predicted was significantly related only with
the “moderate” activities performed during the weekdays
(r Z 0.508, p Z 0.02). The same weekdays data were
related to the Watt max (rZ 0.459, pZ 0.04). The average
time spent in vigorous physical activity related with V0O2
peak (rZ 0.545, pZ 0.01) and with Watt max (rZ 0.547,
p Z 0.01).
Interestingly, the maximal V0E measured at CPET corre-
lated with the total energy expenditure (r Z 0.757,
p Z 0.0001), with the time spent in “moderate” activities
both during the weekdays and the weekend (r Z 0.436,
p Z 0.05; r Z 0.435, p Z 0.05) and during the weekdays
with the time spent in “vigorous” activities (r Z 0.568,
p Z 0.008).
The severity of the airflow obstruction, i.e., FEV1,
correlated with the total energy expenditure during both
weekdays and the weekend (r Z 0.524, p Z 0.01 and
r Z 0.511, p Z 0.02 respectively). During weekdays, FEV1
was related to the active energy expenditure obtained from
activities that require at least two consecutive minutes at
3.0 METS or higher (r Z 0.445, p Z 0.04). However, FEV1
did not explain the variance in V0O2 peak (r Z 0.419,
p Z 0.06) and was a poor determinant of functional exer-
cise tolerance, as assessed by the 6MWD (r Z 0.344,
p Z 0.13).
The 6MWT did not correlate with any physical activity
outcome measurements, assessed by both accelerometer
and questionnaire, but there was a relationship with the
number of steps per day registered during the week
(r Z 0.488, p Z 0.02).Discussion
The most important findings of the present study on daily
PA of adult CF patients with mild to moderate lung function
impairment, were: 1) the levels of PA, measured objec-
tively by means of an accelerometer, are similar through
the week (i.e., weekdays vs weekend days) and to those in
Table 3 Time spent in different physical activity categories as measured by the accelerometer and obtained from HAES
questionnaire during the week in patients with cystic fibrosis (CF) and controls.
Instrument Variable Weekdays Weekend p Value*
Accelerometer Lying time (min/day) CF 444.2  112.8 479.9  85.3 z Z 0.952; p Z 0.341
Control 455  75.2 523  81 z Z L2.215; p Z 0.02
Duration physical
activity (min/day)
CF 224.8  105.1 236.7  139.3 z Z 0.280; p Z 0.779
Control 217  135.3 208.5  112.3 z Z 0.323; p Z 0.746
Mild intensity
activities (min/day)
CF 195.6  93.7 207.3  128.1 z Z 0.168; p Z 0.866
Control 188.8  118.4 187.4  107.4 z Z 0.265; p Z 0.791
Moderate intensity
activities (min/day)
CF 26.1  22.6 27.9  29.3 z Z 0.224; p Z 0.822
Control 24.9  19.7 18.9  17.3 z Z 0.441; p Z 0.65
Vigorous intensity
activities (min/day)
CF 3.65  5.8 1.7  3.5 z Z 1.790; p Z 0.07
Control 3.4  8.8 2.4  3.9 z Z 2.396; p Z 0.016
HAES
questionnaire
Inactive (min/day) CF 43.6  77.2 53.1  85.5 z Z 0.263; p Z 0.79
Control 58.6  61.2 70.9  89.7 z Z 0.426; p Z 0.67
Somewhat inactive
(min/day)
CF 363.5  167.6 262.6  131.6 z Z 2.651; p Z 0.008
Control 306  163.5 317.5  114.5 z Z 2.224; p Z 0.02
Somewhat active
(min/day)
CF 352.2  165.4 460.3  147.1 z Z L2.651; p Z 0.008
Control 475.5  141,6 364.1  100.6 z Z 0.941; p Z 0.34
Very active (min/day) CF 147.5  152.4 114.9  143.2 z Z 1.876; p Z 0.06
Control 82.4  65.8 91.4  90 z Z 1.248; p Z 0.21
Total inactivity
(Inactive þ Somewhat
inactive, min/day)
CF 407.1  154.7 315.7  141.4 z Z 2.464; p Z 0.01
Control 364.7  135.2 388.4  88.4 z Z 1.842; p Z 0.06
Total activity (Somewhat
active þ very active,
min/day)
CF 499.8  168.7 575.3  175.9 z Z L2.203; p Z 0.02
Control 558  138.8 455.6  103.3 z Z 657; p Z 0.51
Data are presented as mean  SD, unless otherwise stated. *p Values are differences between weekdays and weekend days data; sign-
rank non parametric test (p < 0.05).
Bold values are statistically significant.
1892 D. Savi et al.healthy age-matched subjects. In contrast levels of PA
estimated by the HAES questionnaire differ between the
weekdays and the weekend days; 2) accelerometer and
self-report method provide different information, in0
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Figure 1 Relationship between peak oxygen uptake
(V’O2 peak) and physical activities above the threshold of
moderate activity (>4.8 METS); Relationship between peak
oxygen uptake (V’O2 peak) and physical activities above the
threshold of moderate (>4.8 METS) and vigorous (>7.2 METS)
activity.particular self-reported questionnaire overestimates the
levels of PA and likely reflects what CF patients recall
rather than what they actually did; 3) exercise tolerance
and levels of PA above moderate intensity are closely
related.
PA is defined as any bodily movement produced by
skeletal muscles that result in energy expenditure [23].
Therefore, daily PA can be considered the totality of
voluntary movement produced by skeletal muscles during
every day functioning [24]. Habitual PA can be quantified by
direct observation, assessment of energy expenditure and
with self-report questionnaire and motion sensor [25,26].
Quantifying PA in daily life through questionnaires and di-
aries has the advantage of being inexpensive and easy to
apply. However there is now general agreement that in
COPD self-reported physical activity is subject to recall bias
[26], correlates poorly with objectively measured physical
activity [27,28] and does not provide an accurate estimate
of free-living energy expenditure [25]. The main factors
limiting the use of questionnaires in COPD are the accuracy
of perception and recall of information by the subject as
old patients, particularly when recalling light activities
(slow walking, self-care, gardening, home management,
etc) over long periods of time. Limited information is
available on the use of questionnaires in CF population.
Recently, a validated questionnaire was used to evaluate
habitual PA levels among CF adult population compared
with a healthy aged matched group. Despite the results
Measuring habitual physical activity 1893showed that the CF group was comparable to the non-CF
population for moderate and vigorous physical activity,
the lack of objective measurements did not clarify if the
perception and self rating of intensity may have been
subjective [14].
Moreover, the few previous studies comparing the
questionnaires against accelerometers were on adolescent
and young adults with CF and thus the reliability and val-
idity of questionnaire in CF adult population is still not
established. Wells et al. [12], in a small group of adolescent
CF showed that HAES questionnaire data was related to the
activity levels obtained from the accelerometer, suggesting
that this questionnaire was a reliable and valid instrument
to assess different activity levels in CF. However Ruf et al.
[13] found only a moderate correlation between these two
methods of assessment and the results were from a com-
bination of both adolescent and adult CF data. So, this
relatively small proportion of adult participants might be
insufficient to describe a CF adult ‘s activity behavior. Ours
is the first study examining the levels of PA using both a
validated HAES questionnaire [20,12] and an accurate
accelerometer, as showed by Dwyer et al. [29] in a group of
adult CF with a mean age of 33 years.
To allow comparison between motion sensor and HAES
questionnaire data we subdivided PA intensity into com-
parable categories [30]. As described earlier, the time in
minutes spent with an energy expenditure of >3 METS was
considered “mild” activity (i.e., walking at normal speed,
carrying out light household work), time spent at >4.8 METS
was considered “moderate” activity (i.e., brisk walking or
cycling) and activities with an energy expenditure of
>7.2 METS were considered “vigorous” (i.e., activity with
training effects when applied for a sufficient length of time
and at an appropriate training frequency). In the descrip-
tion of HAES questionnaire no METS values were mentioned
for the corresponding activity levels and the examples
given to the participants indicated “inactive” like lying
down, sleeping, resting; “somewhat inactive” like sitting,
reading, watching television; “somewhat active” as
walking, shopping, light household chores and finally “very
active” like running, jumping, skating, skipping. So when
we have compared these two methods, we considered SW
armband “mild” activity represented by the questionnaire
category “somewhat active”, SW armband “moderate”
activity like questionnaire “very active”, SW armband
“lying time” as the questionnaire “ total inactivity”
(inactive þ somewhat inactive) and finally SW armband
“duration of physical activity” like the questionnaire ”total
activity” (somewhat active þ very active”). None of the
physical activity parameter obtained from the question-
naire used in this study was related to the activity levels
measured by the accelerometer. Only the level of “total
inactivity” was adequately estimated by the questionnaire
when compared with data provided by the accelerometer.
Our results raise several issues. First, adults with cystic
fibrosis have similar levels of activity at weekdays and
weekend days, showing that the most sedentary patients
during the working-day also showed the lowest activity in
their free time. Second, an important finding of the present
study is that these adult patients with mild to moderate
pulmonary disease seem to engage in a relatively normal
amount of daily activity, because no differences appearbetween them and healthy age-matched subjects in the
objective time spent at different activity intensities. We
speculate that encouraging exercise as part of their therapy
should help to maintain an active lifestyle. However, our
adult CF patients had some difficulty in remembering the
exact time spent doing both low and moderate intensity
activity; by contrast it seems easier for them to remember
and report the time spent sitting or resting. This ability may
reflect the fact that adult patients have a significantly
longer life expectancy now and spent much of their
weekday working.
Using the same motion sensor for PA monitoring and the
same METS levels, our findings are comparable to those of
Troosters et al. who investigated 20 stable CF adult patients
[8] and to those of Ward et al. [31] who studied 24 adults at
one month post-discharge, for the mean times spent in mild
and vigorous PA. However, our sample recorded a mean of
27 min of moderate PA, greater than the 15 min reported by
Troosters et al. [8] and lower than the 43 min reported by
Ward et al. [31]. Whether this reflects cultural differences
or is an issue of sampling error cannot be addressed here.
We found that V0O2 peak and Watt max were strongly
related to the levels of PA of moderate intensity or greater,
as measured by the accelerometer, particularly during the
weekdays. Moreover patients who spent 30 min per day
performing daily PA above moderate intensity had better
exercise tolerance, i.e., higher V0O2 peak. These findings
support the notion that moderate PA levels should be rec-
ommended to maintain physical fitness, as suggested by the
American College of Sports Medicine [1]. This is in line with
the recent literature that have demonstrated that habitual
PA is a significant predictor of V0O2 peak in CF patients
[4,8].
The present study has some limitations. First, our adult
CF patients had only mild/moderate spirometric impair-
ment. In fact, we were interested at looking the PA
behavior of adults CF patients in the early stage of the
disease. Second, this study involved a relatively small
number of participants which were predominantly male and
thus it is possible that it did not fully represent PA in the
female population. Thus, further research including a more
heterogeneous adult CF population will be needed to
highlight potential gender differences and to better char-
acterize physical activity particularly in a more advanced
disease.
In conclusion, this is the first study in adult CF to provide
evidence that accelerometers should be preferred to
questionnaires in evaluating habitual PA. Using the accel-
erometer we could demonstrate that the time spent in daily
physical activity at different intensities was similar in
adults with cystic fibrosis and in healthy controls and across
the whole week. Questionnaire tends to overestimate the
levels of PA in CF. Finally, the present study clearly showed
in adult CF patients, that exercise tolerance and levels of
PA above moderate intensity are closely related. Further
studies are needed to confirm the results of this single
center trial but if confirmed they indicate that daily ac-
tivity need not be impaired in adults with CF and emphasize
that treatment decisions should be informed by objective
measurements of habitual activity as well as subjective
patient reports which tend to be more positive than is
really the case.
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